- Report
- September 2024
- 351 Pages
Global
From €3990EUR$4,197USD£3,352GBP
- Report
- March 2025
- 281 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- March 2025
- 405 Pages
Global
From €6650EUR$6,995USD£5,587GBP
- Report
- May 2024
- 186 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- November 2021
- 802 Pages
Global
From €4753EUR$5,000USD£3,993GBP

Autophagy is a process of self-degradation of cells in biotechnology. It is a natural process that occurs in all living organisms, and is essential for the maintenance of cellular homeostasis. Autophagy is a key component of the cell's defense system, and is involved in the removal of damaged organelles, proteins, and other cellular components. Autophagy is also involved in the regulation of metabolic processes, and is essential for the maintenance of cellular health.
The autophagy market is a rapidly growing segment of the biotechnology industry. It is driven by the increasing demand for treatments for diseases such as cancer, neurodegenerative diseases, and metabolic disorders. Autophagy-based therapies are being developed to target these diseases, and to improve the efficacy of existing treatments. Additionally, autophagy-based research is being conducted to develop new treatments for a variety of diseases.
Some companies in the autophagy market include Autophagy Therapeutics, Autophagy Technologies, Autophagy Pharma, Autophagy Biotech, and Autophagy Research. Show Less Read more